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Abstract 24 
Benzotriazole (BT) is an anti-corrosive agent, which is well known for its 25 
use in aircraft deicing and antifreeze fluids (ADAFs), but is also used in 26 
dishwasher detergents.  It is highly persistent in the environment, and BT is 27 
therefore frequently found in runoff emanating from large airports, as well as in 28 
the surrounding groundwater. In addition, BT has recently been found to be 29 
ubiquitous in Swiss waste water treatment plant (WWTP) effluents and their 30 
receiving waters.  However, there is very little in the way of chronic toxicity data 31 
available on which to base a sound ecological risk assessment of this chemical.  32 
In vitro assays conducted using a recombinant yeast (anti-)estrogen assay 33 
indicated that BT possessed clear anti-estrogenic properties. The potency of this 34 
chemical was approximately one-hundred times less potent than Tamoxifen, 35 
which was used as a positive control.  However, a subsequent in vivo study, 36 
involving the analysis of vitellogenin induction and somatic indices in adult 37 
fathead minnows exposed to BT at concentrations of 10, 100 and 1000 µg/L for 38 
two weeks, showed no evidence of anti-estrogenic activity of this compound.  The 39 
possibility exists that higher concentrations of BT may yet induce the type of 40 
activity observed in vitro, although the concentrations used here already far 41 
exceed those reported in surface water samples.  Further, adverse effects may 42 
be observed in fish or other organisms exposed to BT for a longer period than 43 
that employed here, although such studies are costly and are unlikely to be 44 
included in standard risk assessment procedures.  A rigorous investigation of the 45 
chronic toxicity of BT is imperative. 46 
 47 
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Introduction 52 
 53 
Benzotriazole (BT) is a commonly used industrial chemical, which was 54 
recently found to be ubiquitously occurring in municipal effluents in Switzerland, 55 
as well as in their receiving waters, at microgram per litre concentrations [1, 2].  56 
Despite this, surprisingly little is known about the environmental contamination of 57 
surface waters by benzotriazole, or indeed about any chronic toxicity which may 58 
result from the exposure of aquatic organisms to this chemical. 59 
 60 
Benzotriazole is an anticorrosive agent, used in aircraft deicing and 61 
antifreeze fluids (ADAFs), which are critical to the safety and smooth running of 62 
airports in cold climates.  As such, ADAFs are used in extremely large quantities; 63 
it is estimated that 3,785 L is used each time a large passenger jet is deiced, and 64 
8 million litres of these chemicals are used per year in Canada alone [3].  For this 65 
reason, much of the attention on environmental concentrations of BT has focused 66 
on runoff from airports, as well as water bodies and ground water systems 67 
receiving such runoff [4-6].  Benzotriazole is also used in machine dishwashing 68 
detergents for silver protection [7], and it is this aspect of its application that was 69 
considered to be responsible for the presence of relatively high concentrations of 70 
the chemical in the Swiss study [1].  In addition, elimination of BT during the 71 
wastewater treatment process appears to be poor.  Consequently, concentrations 72 
of BT measured in sewage effluents are reasonably high.  For example, 73 
concentrations of up to 100 μg/L were detected in secondary effluents emanating 74 
from Swiss waste water treatment plants (WWTP) [1], and an average 75 
concentration of 9.6 μg/L was observed in WWTP effluents around Berlin, 76 
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Germany [8].  Subsequent studies have corroborated these findings, with reports 77 
of mean concentrations of benzotriazoles of 1 to10 μg/L measured in effluents 78 
across Europe [9].  Further, albeit limited, information is available concerning the 79 
occurrence of BT in surface waters.  For example, a recent German study 80 
reported 0.9 μg/L in samples taken from Lake Tegel, 3.4 μg/L in those collected 81 
from the Landwehr Canal, and 0.2 μg/L in bank filtrate (used for drinking water 82 
production) [8].  These data are supported by those published by Reemtsma et 83 
al., where a mean concentration of approximately 0.5 μg/L benzotriazole was 84 
measured in surface waters sampled at five European locations [9]. 85 
 86 
Some of the first toxicity data produced on benzotriazoles and their 87 
derivatives were published by Cancilla et al.[3], who isolated a number of 88 
fractions of ADAFs to determine which of these fractions contributed to their 89 
microtox activity using the Microtox® bioassay.  The first active fraction was found 90 
to be a mixture of benzotriazoles and tolyltriazoles (TTs).  Since then, acute 91 
toxicity assays have revealed that, after 96 h, the LC50 (the concentration 92 
required to cause 50% mortality) was 65 mg/L BT for the fathead minnow 93 
(Pimephales promelas), with a corresponding NOAEC (no observable adverse 94 
effect concentration) of 46 mg/L.  The water flea (Ceriodaphnia dubia) was found 95 
to be slightly less sensitive to BT, with an LC50 of 102 mg/L [10].  These 96 
concentrations are very high, and would suggest that these triazoles are unlikely 97 
to pose an acute threat to wildlife.  However, there is little information that we are 98 
aware of concerning chronic toxicity of these chemicals.  One study has tested 99 
the chronic toxicity of BT in a 21-day reproduction toxicity test using Daphnia 100 
magna, and reported a NOEC (no observed effect concentration) of 3 mg/l [11].  101 
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Based on these data, a predicted no effect concentration of 0.06 mg/L was 102 
calculated for BT [12].  Despite the apparently low acute toxicity of BT, the lack of 103 
chronic toxicity data available for this compound is somewhat surprising given 104 
that BT is highly persistent in the aquatic environment. 105 
 106 
One of the major environmental concerns over BT is the widely 107 
acknowledged fact that it is highly resistant to biodegradation.  For example, 108 
Breedveld et al. incubated BT for a five-month period with innoculum from airport 109 
soil matrices [6].  No evidence of biodegradation was observed, although removal 110 
of BT was observed under aerobic conditions.  This was thought to be a result of 111 
evaporation, since a similar rate of removal was also observed in the abiotic 112 
control.  Various other studies have also reported no evidence of microbial 113 
degradation of BT and its derivatives [12-15].  There have, however, been reports 114 
of photodegradation of this compound [16, 17], which may explain experimental 115 
losses in the absence of biodegradation, and prove useful in the consideration of 116 
remediation processes. 117 
 118 
In addition to the persistent nature of BT, it is a highly soluble compound, 119 
with a water solubility of 28 g/L [2], and it is also weakly hydrophobic, possessing 120 
a log Kow of 1.23 [18].  A combination of these factors suggests that BT will be 121 
both available to aquatic organisms, as well as having the potential to be taken up 122 
by them.  Two derivatives of BT have been detected in tissue extracts of fathead 123 
minnows downstream of ADAF-contaminated effluent outfall [19], demonstrating 124 
that this class of chemicals can be taken up by aquatic life-forms. This evidence, 125 
combined with the fact that BT has been found ubiquitously in those European 126 
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waters for which it has been tested, highlight the need for chronic toxicity tests to 127 
determine whether this compound poses a real risk to the aquatic ecosystem.  128 
The use of BT as a standard ingredient in dishwasher detergents across Europe 129 
indicates that the situation described in Switzerland by Voutsa et al. [1] will be 130 
reflected in other affluent European countries where dishwasher use has risen 131 
over recent years. 132 
 133 
In the current study, BT was tested across a wide range of concentrations 134 
in the yeast estrogen screen for both estrogenic and anti-estrogenic activity.  It 135 
was then assessed for anti-estrogenic activity in a fathead minnow vitellogenin 136 
assay to determine whether the in vitro message could be reproduced in an in 137 
vivo assay.  Three concentrations were tested in vivo: the two lower test 138 
concentrations were within the range detected in the environment.  A third, higher 139 
concentration of BT was also tested to increase the possibility of detecting a 140 
significant effect, thereby providing “proof of principle”. 141 
 142 
Materials and Methods 143 
 144 
Reagents 145 
1H-Benzotriazole (≥99%), 17ß-estradiol (≥98%) and 4-OH-tamoxifen 146 
(98%) were obtained from Sigma Aldrich (Gillingham, Dorset, UK); 5,6-dimethyl-147 
1H-benzotriazole monohydrate (5,6-dimethyl-BT) from Fluka (Gillingham, Dorset, 148 
UK). Oasis HLB (Hydrophilic-Lipophilic Balance) cartridges for solid phase 149 
extraction (SPE) were purchased from Waters (Elstree, Hertfordshire, UK). 150 
 151 
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In vitro assays 152 
The yeast estrogen and anti-estrogen screens have been previously 153 
described [20-22].  Essentially, a gene for the human estrogen receptor (ERα) 154 
has been integrated into the main yeast genome, and is expressed in a form 155 
capable of binding to estrogen response elements and controlling the expression 156 
of the reporter gene, lac-Z.  On activation of the receptor, the lac-Z gene is 157 
expressed, producing the enzyme β-galactosidase, which is secreted into the 158 
medium where it causes a colour change from yellow to red. The intensity of the 159 
red colour can be easily measured by absorbance. 160 
 161 
The standard assay procedure, according to Routledge et al. [20], was 162 
followed for the estrogen screen.  Estradiol (E2) was serially diluted from 2.72x10-163 
6 to 1.33x10-9 g/L, and BT was serially diluted from 0.1 to 5x10-5 g/L.  For the anti-164 
estrogen screen, The E2 was added to the medium, at a concentration of 6.8x10-8 165 
g/L.  This was sufficient to induce a submaximal elevation in background 166 
absorbance in the absence of any other (chemical) influences. In the presence of 167 
a chemical which inhibits the activity of E2, a dose-dependent decrease in β-168 
galactosidase expression (and therefore a reduction in intensity of colour change) 169 
can be observed.  The positive control employed in this assay was the anti-170 
estrogen 4-OH-tamoxifen, which was serially diluted from 4x10-3 to 2x10-6 g/L. 171 
 172 
In vivo assay 173 
 174 
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Test organisms 175 
Juvenile fathead minnows were obtained from Osage Catfisheries (Osage 176 
Beach, MO, USA).  These were maintained in a recirculating aquarium system 177 
until they reached sexual maturity, when males and females could be 178 
distinguished from one another.  Prior to the onset of the study, the fish were 179 
acclimatised in a flow-through tank system at equivalent conditions to those which 180 
they would experience during exposure to the test chemicals. Fish were fed twice 181 
daily throughout, once with frozen brine-shrimp, and once with flaked fish food. 182 
 183 
Test apparatus 184 
The flow-through system consisted of 30 L glass aquaria, to which carbon-185 
filtered, heated (25˚C) water was supplied at a rate of 300 ml/min.  Stock 186 
solutions of the test chemicals were applied using a multichannel peristaltic pump 187 
(205U; Watson -Marlow, Falmouth, Cornwall, UK), and were conveyed to mixing 188 
vessels together with the water supply to ensure as near as possible a 189 
homogeneous solution, prior to delivery to the tanks themselves.  Estradiol was 190 
dissolved in dimethylformamide (DMF), and stocks were delivered at a rate of 191 
0.02 ml/min, resulting in a final DMF concentration in the fish tanks of 67 µl/L, 192 
which is below the concentration recommended (100 µl/L) for solvent use in 193 
aquatic toxicity testing [23].  BT has a high water solubility, and is a very stable 194 
compound, and hence the BT stock solutions were prepared in water, not solvent.  195 
This helped to limit the overall solvent concentration.  The rate of supply of the BT 196 
stocks was 0.1 ml/min.  Tanks were equilibrated with the test chemicals for a 197 
period of 1 week prior to the introduction of the fish.  The photoperiod was 198 
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maintained at 16:8 h light:dark throughout the study period.  Temperature and 199 
dissolved oxygen were monitored daily. 200 
 201 
Experimental design 202 
Two experiments were run concurrently; one using adult male and the 203 
other using adult female fathead minnows.  Since the aim of the study was to 204 
assess the potential for BT to inhibit estrogenic activity, E2 (100 ng/L) was added 205 
to the tank water in which the males were exposed, in order to stimulate an 206 
estrogenic response (in this case, vitellogenin (VTG) induction).  This was not 207 
necessary for the female fish, since their endogenous levels of E2 were sufficient 208 
to detect high levels of VTG without the addition of external estrogens. 209 
 210 
Both the males and the females were exposed to three different 211 
concentrations of BT: 10, 100 and 1000 µg/L.  For females, the negative 212 
response was determined from fish exposed to water alone.  For males, two 213 
controls were employed; a positive control consisting of exposure to 100 ng/l E2, 214 
for direct statistical comparison against the BT-treated groups, and a negative 215 
solvent control (67 µl/L DMF).  The positive control was designed to induce a sub-216 
maximal VTG response, according to previously obtained dose-response data for 217 
E2 in fathead minnows in this system [24].  The negative control was in place in 218 
order that if BT was observed to be anti-estrogenic, it could be judged whether 219 
this chemical was capable of completely inhibiting the effect of E2.  A total of 220 
eight fish were deployed to each treatment tank, and the exposure was 221 
maintained for a period of two weeks.  At the end of the study, fish were 222 
anaesthetised, and the length and weight of each fish was recorded, as well as 223 
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liver and gonad weights.  Blood samples were collected from the caudal peduncle 224 
using heparinised capillary tubes, and were centrifuged at 4000 g for 5 m, 225 
following which plasma was removed and stored at -20˚C prior to analysis for 226 
VTG.  Plasma VTG concentrations were determined using an Enzyme-Linked 227 
Immunosorbent Assay (ELISA) that had previously been validated for 228 
measurement of fathead minnow VTG [25]. 229 
 230 
Water samples were collected for chemical analysis at three points during 231 
the study, once prior to introduction of the fish (t=0), and after one week and two 232 
weeks of exposure (t=1 and t=2, respectively).  Samples collected for BT analysis 233 
were stored at 4˚C (for a maximum of 24 h) prior to extraction, and those 234 
collected for E2 analysis were extracted directly into ethyl acetate, and 235 
subsequently stored at -20˚C until analysis by radioimmunoassay. 236 
 237 
Statistical analysis 238 
The data from the in vivo exposure were assessed for normality of 239 
distribution.  Vitellogenin concentrations were log-transformed to normalise the 240 
data.  The variances of the data sets were also confirmed to be homogeneous.   241 
Data were subsequently analysed by one-way analysis of variance (ANOVA). 242 
 243 
Chemical analyses 244 
 245 
E2 analysis 246 
A volume of 1ml tank water was extracted with 1 ml ethyl acetate, which 247 
was subsequently analysed for E2 concentration using a radioimmunoassay as 248 
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described by Carragher [24]. The detection limit of this assay was 0.02 ng/ml; 249 
cross reactivity with other estrogens (estrone and estriol) was <0.5%, and with 250 
other steroids was <0.005% [26]. 251 
 252 
BT analysis 253 
Enrichment of BT. 254 
Benzotriazole was enriched from 100 ml of tank water through OASIS HLB 255 
cartridges (Waters; 60 mg, 3 ml).  Solid-phase extraction was performed using a 256 
12-port vacuum extraction manifold.  The cartridges were sequentially 257 
conditioned with 2 x 3 ml of methanol and 2 x 3 ml of ddH2O water by applying a 258 
slight vacuum.  Water samples were percolated through the cartridges at a flow 259 
rate of 5ml/min.  The cartridges were dried under vacuum for 10 min and the 260 
analytes were eluted with 1.5 ml of dichloromethane containing 3% methanol.  261 
The eluates were evaporated to dryness under a gentle stream of nitrogen.  Dry 262 
residues were redissolved in 0.5 – 1 ml of the liquid chromatography (LC) mobile 263 
phase (methanol: water 7:3 with 0.4% formic acid).  264 
 265 
Separation, Detection and Quantitation 266 
Underivatized extracts dissolved in the LC mobile phase were analyzed by 267 
LC-MS/MS (mass spectrometry/mass spectrometry) for BT. 5,6-Dimethyl-BT 268 
served as surrogate standard.  An HP Series 1100 system from Agilent (Santa 269 
Clara, California, US), coupled with a triple quadrupole mass spectrometer (API 270 
4000) from Applied Biosystems (Warrington Cheshire, UK) equipped with a 271 
vacuum solvent degassing unit, a binary high-pressure gradient pump, an 272 
automatic sample injector and a column thermostat was used.  Separation was 273 
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accomplished with a 125 x 2.1 mm i.d. endcapped C8 column (Macherey-Nagel, 274 
Düren, Germany).  Isocratic elution was used with a mixture of 275 
methanol/water/formic acid (70:30:0.4) as a mobile phase at a flow rate of 0.2 276 
ml/min.  Detection of the analytes was accomplished with electrospray ionization 277 
in positive mode and using multiple reaction monitoring (MRM).  The following 278 
main ions [M+H]+ and two or three fragment ions for MS determination were 279 
chosen: for BT from m/z 120 to 64.85 and 92.05, and for 5,6-dimethyl-BT from 280 
m/z 148 to 77.05, 90.95 and 92.85.  Due to the highly specific detection, only a 281 
partial chromatographic separation was necessary.  Thus, short analysis times of 282 
only 5 min could be applied.  The quantification of BT was carried out by 283 
calculating the relative response factors based on the area of 5,6-dimethyl-BT.  284 
Six calibration standard solutions (10 to 500 ng absolute) were used to produce a 285 
calibration curve for BT relative to the internal standard.  Recovery was 99±8%.  286 
The limit of detection calculated as three times the standard deviation of low level 287 
standard was 8 ng/l for BT, and the limit of quantitation (10 times the standard 288 
deviation) was 30 ng/l. 289 
 290 
Results and discussion 291 
 292 
The activity of BT in the yeast estrogen screen and anti-estrogen screen 293 
can be seen in Figures 1a and 1b, respectively.  There was no agonistic 294 
estrogenic activity exhibited by this chemical at the concentrations tested in this 295 
study.  Conversely, there was clear evidence of anti-estrogenic activity, with BT 296 
possessing approximately one-hundredth the potency of the positive control, 4-297 
OH-tamoxifen.  Benzotriazole was subsequently assessed for its ability to inhibit 298 
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β-galactosidase activity (the key enzyme response in this assay), in the absence 299 
of the recombinant yeast organism.  There was no evidence of inhibition of β-300 
galactosidase by BT (data not shown), and it was therefore concluded that the 301 
anti-estrogenic activity observed in the yeast anti-estrogen screen was truly 302 
estrogen receptor-mediated. 303 
 304 
There are few examples of industrial endocrine disrupting chemicals 305 
discovered to date which fall into the category of “anti-estrogen”; the majority 306 
have been found to possess either estrogen-agonistic or anti-androgenic 307 
properties.  It was therefore considered that it would be interesting to determine 308 
whether BT could behave in an anti-estrogenic manner in vivo, in a commonly 309 
used ecotoxicology fish species, the fathead minnow, and if so, to examine the 310 
interaction of this chemical with other classes of endocrine disruptors.  A study 311 
was designed to provide an answer to this question - is BT also anti-estrogenic in 312 
vivo?  Both E2-stimulated male fish and adult female fish were used in this study.  313 
The former would provide a measure of whether BT could antagonise E2 activity 314 
via a receptor-mediated pathway.  The rationale of using adult females as well as 315 
E2-stimulated males was that if no effect of BT was observed in the male fish, but 316 
a significant effect (a reduction in the plasma vitellogenin concentration) was 317 
observed in the female fish, the response in the females may be a result of 318 
antagonism via some other mechanism.  For example, some azoles (including 319 
imidazoles and triazoles) are known to possess aromatase-inhibiting properties 320 
[27], and fadrazole is a member of the azole family which is used as a human 321 
pharmaceutical in breast-cancer treatment due to its ability to inhibit aromatase 322 
activity.  Thus, there was the possibility that BT could have anti-estrogenic 323 
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properties not because it was an antagonist of the ER, but because it inhibited 324 
synthesis of estrogens by inhibiting aromatase, the enzyme that converts 325 
androgens to estrogens.  Nevertheless, it is also apparent that the response 326 
observed in the yeast anti-estrogen screen was receptor-mediated, and so this 327 
was the expected mode of action.   328 
 329 
Analysis of the BT concentrations during the in vivo exposure revealed that 330 
the levels were remarkably consistent between different tanks, as well as across 331 
all timepoints, with mean values falling between 80 and 86% of the nominal 332 
values in all tanks.  The mean E2 concentrations in the tanks containing male fish 333 
were slightly lower than nominal concentrations, as is frequently observed in such 334 
studies.  Nevertheless, the measured concentrations of 74, 70, 57 and 67 ng/L 335 
were sufficient to induce measurable, but submaximal, vitellogenin synthesis in all 336 
tanks.  Despite the slightly lower concentration (57 ng/l) of E2 measured in one of 337 
the tanks (tank 5, which contained E2 plus 100 µg/L BT), it was estimated that the 338 
concentration of plasma vitellogenin inducible by the respective concentrations of 339 
E2 in the fish in all four E2-treated tanks would not be significantly different from 340 
one another (based on concentration-response data from Brian et al. [24].  341 
Therefore, if any differences were observed, they would be attributable to the 342 
presence of BT and not to the slightly different concentrations of E2. 343 
 344 
The gonadosomatic (GSI) indices of fish in each treatment group are 345 
shown in Figure 2.  There were no significant differences observed due to any of 346 
the treatments.  Although there was an apparent increase of GSI in the female 347 
fish exposed to the highest dose of BT (1000 μg/L), there were no statistically 348 
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significant differences between treatment groups.  The groups of male fish 349 
exposed to E2 (with or without BT) all have slightly reduced GSIs compared to 350 
the negative control, which is almost certainly a result of exposure of the fish to 351 
E2 [28]; none of the BT treatments were significantly different from that of the 352 
(positive) E2-control.  In summary, BT had no effect on the GSI of either sex of 353 
fish. 354 
 355 
Plasma vitellogenin concentrations measured in male and female fathead 356 
minnows are shown in Figures 3a and 3b, respectively.  There were no 357 
observable differences between the E2-control group, and the E2+BT-treated 358 
male fish.  Likewise, there were no discernible differences between the control 359 
group and any of the groups of BT-exposed female fish.  Thus, BT had no effect 360 
whatsoever on the plasma vitellogenin concentrations of either sex.  These data 361 
imply that BT possesses no anti-estrogenic activity either receptor-mediated or 362 
via any other mechanistic pathway in fathead minnows at the concentrations 363 
tested here. 364 
 365 
The log KOW of BT is 1.23 [18], indicating that this chemical is weakly 366 
lipophilic.  It is therefore possible that, not only will BT be readily absorbed by fish 367 
from water bodies in which it is present, but that it may also accumulate to some 368 
degree in their tissues.  Although BT itself has not yet been measured in aquatic 369 
organisms, two related chemicals (5-methyl-1H-benzotriazole and 4-methyl-1H-370 
benzotriazole) have been detected in tissue extracts from fathead minnows 371 
placed downstream of an effluent outfall which receives ADAF-contaminated 372 
runoff [19].  It seems legitimate, therefore, to infer that BT is also capable of 373 
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crossing the water/organism interface in fathead minnows.  To our knowledge, 374 
the bioconcentration factor (BCF) of BT has not yet been determined, and so the 375 
degree to which it accumulates in aquatic organisms is as yet unknown. 376 
 377 
Although a positive control (in the form of either a known anti-estrogen or 378 
aromatase-inhibiting chemical) was not used in this study, it is unlikely that the 379 
lack of anti-estrogenic activity observed in our studies was a result of the lack of 380 
ability of our fish to respond to such chemicals.  It has already been demonstrated 381 
that a suppressed vitellogenin response occurs in juvenile fathead minnows 382 
exposed to a pharmaceutical anti-estrogen [29].  Further, the aromatase inhibitor 383 
fadrazole has been shown to reduce vitellogenin concentrations in adult female 384 
fathead minnows [30, 31].  These data suggest that if BT does act via either a 385 
receptor-mediated anti-estrogenic pathway (as implied in the in vitro study 386 
conducted here), or via an anti-aromatase pathway similar to that of some of its 387 
related azole family members [27], effects would be observable using the fathead 388 
minnow vitellogenin assay undertaken here. 389 
 390 
It is still possible that higher concentrations of BT would demonstrate some 391 
anti-estrogenic activity, but the concentrations used here (up to 1000 µg/L) far 392 
exceed those reported in surface waters (up to 3.69 µg/L in the River Glatt, 393 
Switzerland, [1]; 0.9 µg/L and 3.4 µg/L in Lake Tegel and the Landwehr Canal, 394 
respectively [8]).  However, much higher concentrations of BT (up to 126 mg/L) 395 
have been measured in groundwater samples collected from a perched water 396 
monitoring well at an international airport [4].  It is also feasible that effects could 397 
be induced by longer-term exposures, which may give this moderately lipophilic 398 
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substance the potential to accumulate to an effective concentration in the tissues 399 
of the exposed organism. 400 
 401 
In summary, although clear anti-estrogenic activity of BT was 402 
demonstrated in vitro, no evidence of anti-estrogenic activity was observed in the 403 
in vivo assay undertaken for this study.  Nonetheless, we consider that the lack of 404 
chronic toxicity data currently available for this compound is unacceptable, 405 
particularly given that it has been described as “toxic to aquatic organisms and 406 
can cause long-term adversary effects in the aquatic environment” [12], is highly 407 
persistent in the aquatic environment, and has been found to be ubiquitous in 408 
Swiss river WWTP effluents and their receiving waters.  More effort should be 409 
applied in determining the long-term risk of this chemical to aquatic organisms. 410 
 411 
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Figure Legends 552 
 553 
Figure 1 554 
Activity of benzotriazole in A) the recombinant yeast estrogen screen; B) the 555 
recombinant yeast anti-estrogen screen.  The ‘control’ sample shown in figure 1B 556 
shows the activity of the assay with a submaximal concentration of estradiol 557 
added to the yeast medium. 558 
 559 
Figure 2 560 
Gonadosomatic indices (GSI) of both male and female adult fathead minnows 561 
exposed to benzotriazole (BT)for 14 d. Males were exposed concurrently to a 562 
nominal concentration of 100  ng/l estradiol (E2).  Results are presented as 563 
means with standard error (n=8 in all cases). 564 
 565 
Figure 3 566 
Vitellogenin concentrations in A) male fathead minnows exposed to various 567 
concentrations of benzotriazole (BT), plus a constant concentration of estradiol 568 
(E2) for 14 d; B) female fathead minnows exposed to BT alone for 14 d.  In every 569 
treatment, n=8, and each dot represents the plasma vitellogenin concentration of 570 
a single fish (some points overlay others, hence 8 dots are not apparent in each 571 
treatment). 572 
